| Connor A Patterson, MD | |
|
1985 Jefferson Davis Hwy, Fredericksburg, VA 22401-6233 | |
| (540) 373-6647 | |
| (540) 479-1656 |
| Full Name | Connor A Patterson |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 18 Years |
| Location | 1985 Jefferson Davis Hwy, Fredericksburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548475189 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Washington Hospital | Fredericksburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Dermatology Sc | 8628353380 | 160 |
| Pinnacle Dermatology Sc | 8628353380 | 160 |
News Archive
Sigma-Aldrich(R) (Nasdaq: SIAL) announced today that scientists at its new Sigma Advanced Genetic Engineering (SAGE(TM)) Labs in St. Louis will leverage its exclusive CompoZr(TM) Zinc Finger Nuclease (ZFN) gene editing technology (www.compozrzfn.com) to define, develop and offer a new generation of genetically-engineered rodent research models. Such models are commonly used to study disease states in humans and play a key role in the drug discovery process.
Carriage Services, Inc. today announced that it has updated its "Company & Investment Profile,".Carriage's updated Company & Investment Profile includes updated discussions of Carriage's business, operating and growth strategies, historical financial information, financial outlook and more.
Orthopaedic surgeons have traditionally been taught that certain types of knee symptoms indicate damage to specialized structures called the menisci.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
Spectral Diagnostics Inc., a company developing products for the treatment of sepsis, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption (IDE) approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, allowing the Company to conduct a pivotal trial in the United States.
› Verified 5 days ago
| Entity Name | Virginia Dermatology And Skin Surgery Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598056582 PECOS PAC ID: 0547439200 Enrollment ID: O20110815000231 |
News Archive
Sigma-Aldrich(R) (Nasdaq: SIAL) announced today that scientists at its new Sigma Advanced Genetic Engineering (SAGE(TM)) Labs in St. Louis will leverage its exclusive CompoZr(TM) Zinc Finger Nuclease (ZFN) gene editing technology (www.compozrzfn.com) to define, develop and offer a new generation of genetically-engineered rodent research models. Such models are commonly used to study disease states in humans and play a key role in the drug discovery process.
Carriage Services, Inc. today announced that it has updated its "Company & Investment Profile,".Carriage's updated Company & Investment Profile includes updated discussions of Carriage's business, operating and growth strategies, historical financial information, financial outlook and more.
Orthopaedic surgeons have traditionally been taught that certain types of knee symptoms indicate damage to specialized structures called the menisci.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
Spectral Diagnostics Inc., a company developing products for the treatment of sepsis, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption (IDE) approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, allowing the Company to conduct a pivotal trial in the United States.
› Verified 5 days ago
| Entity Name | Pinnacle Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861930984 PECOS PAC ID: 8628353380 Enrollment ID: O20200911001788 |
News Archive
Sigma-Aldrich(R) (Nasdaq: SIAL) announced today that scientists at its new Sigma Advanced Genetic Engineering (SAGE(TM)) Labs in St. Louis will leverage its exclusive CompoZr(TM) Zinc Finger Nuclease (ZFN) gene editing technology (www.compozrzfn.com) to define, develop and offer a new generation of genetically-engineered rodent research models. Such models are commonly used to study disease states in humans and play a key role in the drug discovery process.
Carriage Services, Inc. today announced that it has updated its "Company & Investment Profile,".Carriage's updated Company & Investment Profile includes updated discussions of Carriage's business, operating and growth strategies, historical financial information, financial outlook and more.
Orthopaedic surgeons have traditionally been taught that certain types of knee symptoms indicate damage to specialized structures called the menisci.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
Spectral Diagnostics Inc., a company developing products for the treatment of sepsis, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption (IDE) approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, allowing the Company to conduct a pivotal trial in the United States.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Connor A Patterson, MD 1985 Jefferson Davis Hwy, Fredericksburg, VA 22401-6233 Ph: (225) 766-5151 | Connor A Patterson, MD 1985 Jefferson Davis Hwy, Fredericksburg, VA 22401-6233 Ph: (540) 373-6647 |
News Archive
Sigma-Aldrich(R) (Nasdaq: SIAL) announced today that scientists at its new Sigma Advanced Genetic Engineering (SAGE(TM)) Labs in St. Louis will leverage its exclusive CompoZr(TM) Zinc Finger Nuclease (ZFN) gene editing technology (www.compozrzfn.com) to define, develop and offer a new generation of genetically-engineered rodent research models. Such models are commonly used to study disease states in humans and play a key role in the drug discovery process.
Carriage Services, Inc. today announced that it has updated its "Company & Investment Profile,".Carriage's updated Company & Investment Profile includes updated discussions of Carriage's business, operating and growth strategies, historical financial information, financial outlook and more.
Orthopaedic surgeons have traditionally been taught that certain types of knee symptoms indicate damage to specialized structures called the menisci.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
Spectral Diagnostics Inc., a company developing products for the treatment of sepsis, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption (IDE) approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, allowing the Company to conduct a pivotal trial in the United States.
› Verified 5 days ago
Dr. Theresa Conologue, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1101 Sam Perry Blvd Ste 121, Fredericksburg, VA 22401 Phone: 540-899-1600 | |
Dr. Henry Gerard Sacks, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2301 Fall Hill Ave, Suite 106, Fredericksburg, VA 22401 Phone: 554-373-1080 Fax: 540-373-1094 | |
Dr. Terri P. Morris, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3501 Lafayette Blvd, Fredericksburg, VA 22408 Phone: 540-371-7118 Fax: 540-371-3248 | |
Michael Peter Stevens, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1300 Thornton St, Fredericksburg, VA 22401 Phone: 540-371-3115 Fax: 540-372-9860 | |
Patricia P Stevens, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1300 Thornton St, Fredericksburg, VA 22401 Phone: 540-371-3115 Fax: 540-372-9860 | |
Mark P. Eid, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1985 Jefferson Davis Hwy, Fredericksburg, VA 22401 Phone: 540-373-6647 Fax: 540-479-1656 |